共 115 条
- [1] Nelson HD(2008)Benefits of hormone replacement therapy in post menopausal women Menopause. Lancet 371 760-70
- [2] Canderelli R(2007)Menopausal hormone therapy J Am Acad Nurse Pract 19 635-41
- [3] Leccesse LA(2005)Cardiovascular pharmacology of hormone replacement therapy J Obstet Gynaecol Can 27 137-62
- [4] Miller NL(1999)Postmenopausal hormone replacement therapy: Scientific review Drugs Aging 15 219-34
- [5] Bhavnani BR(2002)Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 288 872-81
- [6] Strickler RC(1998)Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) JAMA 280 605-13
- [7] Rosano GM(2002)Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results from the Women’s Health Initiative randomized controlled trial JAMA 288 49-57
- [8] Panina G(2002)Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia JAMA 288 321-33
- [9] Nelson HD(2008)HRT and breast cancer: Impact on population risk and incidence Med J Aust 188 641-44
- [10] Humphrey LL(2005)Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication Eur J Cancer 41 1775-81